Panjit Chieosilapatham

Panjit Chieosilapatham

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2017 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
François NiyonsabaFrançois Niyonsaba
François Niyonsaba
CKChanisa Kiatsurayanon
Chanisa Kiatsurayanon
PCPanjit Chieosilapatham
Panjit Chieosilapatham
HOHideoki Ogawa
Hideoki Ogawa

4 August 2017 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
PCPanjit Chieosilapatham
Panjit Chieosilapatham
HOH Ogawa
H Ogawa
François NiyonsabaFrançois Niyonsaba
François Niyonsaba
Summary: Anti-microbial peptides or host defence peptides are small molecules that display both anti-microbial activities and complex immunomodulatory functions to protect against various diseases. Among these peptides, the human β-defensins (hBDs) are localized primarily in epithelial surfaces, including those of the skin, where they contribute to protective barriers. In atopic dermatitis skin lesions, altered skin barrier and immune dysregulation are believed to be responsible for reduced hBD synthesis. Impaired hBD expression in the skin is reportedly the leading cause of increased susceptibility to bacterial and viral infection in patients with atopic dermatitis. Although hBDs have considerable beneficial effects as anti-microbial agents and immunomodulators and may ameliorate atopic dermatitis clinically, recent evidence has also suggested the negative effects of hBDs in atopic dermatitis development. In the current review, we provide an overview of the regulation of hBDs and their role in the pathogenesis of atopic dermatitis. The efforts to utilize these molecules in clinical applications are also described.

1 September 2016 in Journal of Dermatological Science
Verified
Journal Article
Closed access
CKChanisa Kiatsurayanon
Chanisa Kiatsurayanon
François NiyonsabaFrançois Niyonsaba
François Niyonsaba
PCPanjit Chieosilapatham
Panjit Chieosilapatham
KOKo Okumura
Ko Okumura
SIShigaku Ikeda
Shigaku Ikeda
HOHideoki Ogawa
Hideoki Ogawa

28 May 2018 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
PCPanjit Chieosilapatham
Panjit Chieosilapatham
SIShigaku Ikeda
Shigaku Ikeda
HOHideoki Ogawa
Hideoki Ogawa
FNFrancois Niyonsaba
Francois Niyonsaba
Cathelicidins form one of the major families of antimicrobial peptides and have been identified in many vertebrates, including humans. LL-37, the only human member of the cathelicidin family, is detected in most sites of the human body that is normally exposed to microbes, including the epithelial lining of the skin, gastrointestinal tract, genitourinary tract and lungs. This peptide is also expressed by a variety of epithelial cells and immune cells, such as neutrophils, monocytes and mast cells. LL-37 has emerged as a key component of innate immunity due to its direct antimicrobial activity against a broad spectrum of invading pathogens. It also exhibits diverse immunomodulatory functions by activating both pro- and anti-inflammatory mediators; inducing cell migration, proliferation and differentiation; and regulating apoptosis of epithelial cells and neutrophils. Given that the phenotypic and functional properties of immune compartments are different and significantly impacted by the anatomical sites, tissue-specific factors of host origin and microbial communities play important roles in the regulation of LL-37. This review summarizes the expression and biological functions of LL-37 and discusses its significant roles in the innate immune system based on its anatomical distribution.

26 June 2017 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
KYKensuke Yanashima
Kensuke Yanashima
PCPanjit Chieosilapatham
Panjit Chieosilapatham
EYEri Yoshimoto
Eri Yoshimoto
KOKo Okumura
Ko Okumura
HOHideoki Ogawa
Hideoki Ogawa
François NiyonsabaFrançois Niyonsaba
François Niyonsaba

1 September 2020 in Journal of Dermatological Science
Verified
Journal Article
Closed access
PCPanjit Chieosilapatham
Panjit Chieosilapatham
HYHainan Yue
Hainan Yue
SIShigaku Ikeda
Shigaku Ikeda
HOHideoki Ogawa
Hideoki Ogawa
François NiyonsabaFrançois Niyonsaba
François Niyonsaba